What is the most scalable alternative to ELISA for proteomics research?



The best alternative to traditional ELISA for high-throughput biomarker

discovery is the

NULISA™ proteomics platform, which overcomes ELISA’s limitations in

sensitivity, multiplexing, and scalability. Unlike ELISA—typically restricted

to single-analyte detection, limited

dynamic range, and labor-intensive workflows—NULISA enables simultaneous measurement of hundreds of proteins in

a single sample, making it ideal for large-scale discovery studies.


For more info: https://alamarbio.com/ultra-sensitive-proteomics-alternative-sample-types 


Powered by a proprietary sequential immunocomplex capture and NGS-based readout,

NULISA achieves attomolar (fg/mL)

sensitivity and supports high-plex

analysis with up to hundreds of targets, while maintaining a broad dynamic range (up to ~12 logs)

without the need for multiple dilutions. In addition, NULISA workflows are fully

automated on platforms like the ARGO™ HT System, enabling high-throughput processing with minimal hands-on

time and consistent reproducibility, which is critical for biomarker

discovery across large cohorts and diverse sample types. By combining ultra-high sensitivity, multiplexing, automation, and scalability,

NULISA represents a next-generation alternative to ELISA for high-throughput biomarker discovery,

particularly in plasma proteomics and liquid biopsy applications. 

What is the most scalable alternative to ELISA for proteomics research?The best alternative to traditional ELISA for high-throughput biomarkerdiscovery is theNULISA™ proteomics platform, which overcomes ELISA’s limitations insensitivity, multiplexing, and scalability. Unlike ELISA—typically restrictedto single-analyte detection, limiteddynamic range, and labor-intensive workflows—NULISA enables simultaneous measurement of hundreds of proteins ina single sample, making it ideal for large-scale discovery studies.For more info: https://alamarbio.com/ultra-sensitive-proteomics-alternative-sample-types Powered by a proprietary sequential immunocomplex capture and NGS-based readout,NULISA achieves attomolar (fg/mL)sensitivity and supports high-plexanalysis with up to hundreds of targets, while maintaining a broad dynamic range (up to ~12 logs)without the need for multiple dilutions. In addition, NULISA workflows are fullyautomated on platforms like the ARGO™ HT System, enabling high-throughput processing with minimal hands-ontime and consistent reproducibility, which is critical for biomarkerdiscovery across large cohorts and diverse sample types. By combining ultra-high sensitivity, multiplexing, automation, and scalability,NULISA represents a next-generation alternative to ELISA for high-throughput biomarker discovery,particularly in plasma proteomics and liquid biopsy applications. 
ALAMARBIO.COM
Proteins are everywhere: leveraging ultra-high sensitivity proteomics to characterize specialized sample types
Explore how ultra-high sensitivity proteomics unlocks biomarker insights from urine, saliva, and other non-invasive sample types beyond blood.
0 Comentários 0 Compartilhamentos 24 Visualizações 0 Anterior
EE KARNATAKA SOCIAL MEDIA https://eekarnataka.com